{"id":71466,"date":"2026-05-20T12:20:00","date_gmt":"2026-05-20T12:20:00","guid":{"rendered":"https:\/\/medsbase.com\/b12-cyanocobalamin\/"},"modified":"2026-10-15T10:33:56","modified_gmt":"2026-10-15T10:33:56","slug":"b12-cyanocobalamin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/fr\/product\/b12-cyanocobalamin\/","title":{"rendered":"Vitamin B12 (Cyanocobalamin) Injectable \u2014 Pharmaceutical Grade"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u00e9ponse rapide \u2014 Qu'est-ce que la B12 (Cyanocobalamine) injectable ?<\/h3>\n<p style=\"margin: 0;\"><strong>Vitamine B12 (Cyanocobalamine)<\/strong> est la forme synth\u00e9tique cyano-coordonn\u00e9e de la famille des coenzymes cobalamines (CAS 68-19-9, MF C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P, MW 1355,37 g\/mol). Fourni ici sous forme de <strong>flacon injectable multidose de 10 mg pour 10 mL<\/strong> (1 mg\/mL pre-formulated sterile aqueous solution \u2014 no reconstitution required) for studies and companion-protocol use alongside the peptide catalogue. Cyanocobalamin is the most-cited B12 form in published studies because it is the most chemically stable: cells take it up via the transcobalamin-II \/ cubilin pathway and convert it intracellularly to the two biologically-active cobalamin forms \u2014 <strong>m\u00e9thylcobalamine<\/strong> (cofacteur pour la m\u00e9thionine synthase \/ cycle SAM \/ m\u00e9tabolisme \u00e0 un carbone) et <strong>ad\u00e9nosylcobalamine<\/strong> (cofactor for methylmalonyl-CoA mutase \/ odd-chain fatty acid metabolism \/ TCA entry). For clinical studies use only. <em>Pas un peptide<\/em> \u2014 petite mol\u00e9cule corrino\u00efde centr\u00e9e sur le cobalt.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce que vous obtenez avec MedsBase :<\/strong> Pre-formulated sterile aqueous solution \u00b7 \u226599% HPLC-verified cyanocobalamin \u00b7 COA available on request \u00b7 Discreet temperature-controlled packaging \u00b7 Worldwide peptide courier \u00b7 1,400+ verified <a href=\"https:\/\/medsbase.com\/fr\/reviews\/\">avis clients<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Chaque commande est couverte par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\"><strong>Politique de R\u00e9exp\u00e9ditions Garanties<\/strong><\/a> \u2014 si votre colis n'arrive pas dans les 20 jours ouvrables, nous le r\u00e9exp\u00e9dions.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Sp\u00e9cification<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">D\u00e9tail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Classe de compos\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Corrino\u00efde \u00e0 centre de cobalt ; coenzyme ; famille de la vitamine B12 ; cofacteur de petite mol\u00e9cule ; <em>pas un peptide<\/em><\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Nom chimique<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Cyanocobalamine (synonymes : Vitamine B12, cobalamine (forme cyano), CN-B12 ; la forme synth\u00e9tique stabilis\u00e9e par coordination cyano de la famille des cobalamines)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u00e9ro CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">68-19-9 (cyanocobalamine) ; CAS des cobalamines apparent\u00e9es \u2014 m\u00e9thylcobalamine 13422-55-4, hydroxocobalamine 13422-51-0, ad\u00e9nosylcobalamine 13870-90-1 (non fournies ici)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formule mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1355,37 g\/mol<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>M\u00e9canisme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">La cyanocobalamine p\u00e9n\u00e8tre dans les cellules via la voie m\u00e9di\u00e9e par le r\u00e9cepteur transcobalamine-II \u2192 cubiline et est convertie intracellulairement par la m\u00e9thionine synthase r\u00e9ductase (MTRR) et la prot\u00e9ine de type cblA de l'acidurie m\u00e9thylmalonique (MMAA) en les deux coenzymes de cobalamine biologiquement actives \u2014 <strong>m\u00e9thylcobalamine<\/strong> (cofacteur cytosolique pour la m\u00e9thionine synthase) et <strong>ad\u00e9nosylcobalamine<\/strong> (cofacteur mitochondrial pour la m\u00e9thylmalonyl-CoA mutase). Les deux coenzymes sont essentielles respectivement pour le m\u00e9tabolisme du carbone unique \/ m\u00e9thylation et du propionyl-CoA \/ acides gras \u00e0 cha\u00eene impaire.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">n\/a (coenzyme corrino\u00efde de petite mol\u00e9cule \u2014 pas un peptide)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forme et concentration<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Solution aqueuse st\u00e9rile pr\u00e9formul\u00e9e<\/strong> \u2014 1 mg\/mL cyanocobalamin in physiological-buffer base, 10 mL multi-dose vial (10 mg total cyanocobalamin per vial). Characteristic deep red colour from the cobalt-corrin chromophore. <strong>Aucune reconstitution n\u00e9cessaire<\/strong> \u2014 pr\u00e9lever aseptiquement avec une seringue st\u00e9rile.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puret\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599 % (v\u00e9rifi\u00e9 par HPLC) ; r\u00e9f\u00e9rence standard de cyanocobalamine de qualit\u00e9 USP. COA disponible sur demande.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Tr\u00e8s soluble dans l'eau (~12,5 mg\/mL de limite de solubilit\u00e9 \u00e0 25 \u00b0C) ; la solution pr\u00e9formul\u00e9e est bien en dessous de la saturation. Stable en tampon aqueux \u00e0 pH 4\u20137. \u00c9viter les conditions alcalines (formation rapide d'hydroxocobalamine) et les conditions fortement r\u00e9ductrices (g\u00e9n\u00e9ration de cob(II)alamine).<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Stockage<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Conserver au r\u00e9frig\u00e9rateur entre 2 et 8 \u00b0C ; <strong>prot\u00e9ger de la lumi\u00e8re<\/strong> (la cyanocobalamine est photosensible \u2014 la lumi\u00e8re UV\/bleue catalyse la conversion cyano en hydroxo). Utiliser le flacon multidose dans les 60 jours suivant la premi\u00e8re ponction. Ne pas congeler (la formation de cristaux de glace peut fissurer le flacon en verre et risque une d\u00e9gradation photolytique lors d'un stockage prolong\u00e9 au cong\u00e9lateur). Utiliser avant la date de p\u00e9remption indiqu\u00e9e sur l'\u00e9tiquette du flacon (g\u00e9n\u00e9ralement 24 mois apr\u00e8s la fabrication).<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Qu'est-ce que la vitamine B12 (cyanocobalamine) ?<\/h2>\n<p><strong>Cyanocobalamine<\/strong> (CAS 68-19-9) est la forme synth\u00e9tique, cyano-coordonn\u00e9e, de la famille des cobalamines de la vitamine B12. Structurellement, il s'agit d'un complexe corrino\u00efde centr\u00e9 sur le cobalt : un cycle macrocyclique \u00e0 19 atomes (le cycle corrine, similaire en g\u00e9om\u00e9trie au cycle porphyrine de l'h\u00e9moglobine mais distinct en composition) coordonne un ion cobalt central dans son \u00e9tat d'oxydation 3+, avec une queue de nucl\u00e9otide de dim\u00e9thylbenzimidazole pendante sous le cycle et un groupe cyano (-CN) occupant la position axiale sup\u00e9rieure. Formule mol\u00e9culaire C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P, molecular weight 1355.37 g\/mol. The molecule is intensely red \u2014 its visible-spectrum absorption (\u03bbmax ~360, ~520, ~550 nm) is what gives B12 solutions their characteristic deep pink-red colour. The &#8220;cyano&#8221; form is a synthetic stabilisation choice rather than a biologically-significant species in vivo. Cobalamins in cells exist primarily as <strong>m\u00e9thylcobalamine<\/strong> (un groupe m\u00e9thyle en position axiale sup\u00e9rieure \u2014 le cofacteur cytosolique de la m\u00e9thionine synthase) et <strong>ad\u00e9nosylcobalamine<\/strong> (a 5\u2032-deoxyadenosyl group on the upper axial position \u2014 the mitochondrial cofactor for methylmalonyl-CoA mutase). These two active forms are interconverted by dedicated cellular enzymes and are not commercially supplied in stable injectable form because of their light-sensitivity. Cyanocobalamin is supplied instead because the cyano group is photochemically and thermally stable, and cells convert cyanocobalamin to the methyl and adenosyl forms intracellularly via methionine synthase reductase (MTRR) and the methylmalonic aciduria cblA-type protein (MMAA), respectively. In the studies and clinical context, cyanocobalamin injectable preparations are the canonical supplemental form. The 10 mL multi-dose vial format (1 mg\/mL \u00d7 10 mL = 10 mg per vial) supplied here matches the standard pharmaceutical preparation pattern. MedsBase stocks this format in the peptide-studies catalogue as a small-molecule companion compound used in protocols that combine peptide studies with cobalamin-axis biology \u2014 recovery, methylation-cycle studies, hematology, cognitive studies with nootropic peptides, and energy-metabolism panels where the SAM cycle is engaged. <\/p>\n<h2>M\u00e9canisme d'action \u2014 Deux r\u00e9actions coenzymatiques de la cobalamine<\/h2>\n<p>Le m\u00e9canisme biologique de la B12 \/ cyanocobalamine est la somme des deux r\u00e9actions enzymatiques catalys\u00e9es par les coenzymes actives de cobalamine qui en d\u00e9rivent :<\/p>\n<ul>\n<li><strong>Absorption cellulaire via la transcobalamine-II \u2192 cubiline \/ m\u00e9galine<\/strong> \u2014 La cyanocobalamine libre dans le liquide extracellulaire est li\u00e9e par la transcobalamine-II (TCII), et le complexe TCII-B12 est absorb\u00e9 par le syst\u00e8me r\u00e9cepteur cubiline \/ m\u00e9galine \u00e0 la surface des cellules. La lib\u00e9ration intracellulaire dans le lysosome est suivie d'un transport dans le cytosol via le complexe d'efflux LMBRD1 \/ ABCD4.<\/li>\n<li><strong>Conversion intracellulaire en coenzymes actives<\/strong> \u2014 Dans le cytosol, la m\u00e9thionine synthase r\u00e9ductase (MTRR) r\u00e9duit et m\u00e9thyle la cyanocobalamine en <strong>m\u00e9thylcobalamine<\/strong> (la forme cytosolique active), perdant le groupe cyano sous forme de cyanure (qui est ensuite d\u00e9toxifi\u00e9 par le syst\u00e8me rhodan\u00e8se \/ thiosulfate aux tr\u00e8s faibles quantit\u00e9s g\u00e9n\u00e9r\u00e9es). Dans la mitochondrie, la prot\u00e9ine de type cblA de l'acidurie m\u00e9thylmalonique (MMAA) plus la m\u00e9thionine synthase r\u00e9ductase convertit la cyanocobalamine en <strong>ad\u00e9nosylcobalamine<\/strong> (la forme mitochondriale active).<\/li>\n<li><strong>M\u00e9thylcobalamine \u2192 m\u00e9thionine synthase (cytosolique, cycle un carbone \/ SAM)<\/strong> \u2014 La m\u00e9thionine synthase catalyse le transfert d'un groupe m\u00e9thyle du 5-m\u00e9thyl-t\u00e9trahydrofolate vers l'homocyst\u00e9ine, r\u00e9g\u00e9n\u00e9rant la m\u00e9thionine et le t\u00e9trahydrofolate. C'est le lien critique entre la B12, le folate et le cycle m\u00e9thionine \/ SAM. Le SAM (S-ad\u00e9nosyl-m\u00e9thionine, g\u00e9n\u00e9r\u00e9 \u00e0 partir de m\u00e9thionine + ATP) est le donneur universel de groupes m\u00e9thyle pour les centaines de r\u00e9actions de m\u00e9thylation cellulaires \u2014 m\u00e9thylation de l'ADN, m\u00e9thylation des histones, m\u00e9thylation des phospholipides, m\u00e9thylation des neurotransmetteurs (cat\u00e9cholamines, m\u00e9latonine), biosynth\u00e8se de la cr\u00e9atine. Une carence en B12 perturbe donc tout le programme de m\u00e9thylation de la cellule et est la base mol\u00e9culaire des s\u00e9quelles h\u00e9matologiques (an\u00e9mie m\u00e9galoblastique due \u00e0 une synth\u00e8se de thymidine alt\u00e9r\u00e9e par la m\u00e9thylation de l'ADN) et neurologiques (d\u00e9my\u00e9linisation due \u00e0 une m\u00e9thylation des phospholipides alt\u00e9r\u00e9e) de la carence clinique en B12.<\/li>\n<li><strong>Ad\u00e9nosylcobalamine \u2192 m\u00e9thylmalonyl-CoA mutase (mitochondriale, entr\u00e9e propionyl-CoA \/ TCA)<\/strong> \u2014 La m\u00e9thylmalonyl-CoA mutase catalyse le r\u00e9arrangement intramol\u00e9culaire du (R)-m\u00e9thylmalonyl-CoA en succinyl-CoA. C'est le point d'entr\u00e9e m\u00e9tabolique des substrats g\u00e9n\u00e9rateurs de propionyl-CoA \u2014 acides gras \u00e0 cha\u00eene impaire, acides amin\u00e9s \u00e0 cha\u00eene ramifi\u00e9e (valine, isoleucine, m\u00e9thionine), cha\u00eene lat\u00e9rale du cholest\u00e9rol. Une carence en ad\u00e9nosylcobalamine provoque une accumulation de m\u00e9thylmalonate (le biomarqueur diagnostique de la carence clinique en B12) et alt\u00e8re l'oxydation du propionyl-CoA \/ des graisses \u00e0 cha\u00eene impaire.<\/li>\n<li><strong>Connexion \u00e0 l'axe NAD et au croisement du m\u00e9tabolisme \u00e0 un carbone<\/strong> \u2014 La r\u00e9action B12 \/ m\u00e9thionine-synthase se situe au m\u00eame n\u0153ud m\u00e9tabolique que les r\u00e9actions de m\u00e9thylation consommatrices de SAM catalys\u00e9es par des centaines de m\u00e9thyltransf\u00e9rases cellulaires, y compris la NNMT (nicotinamide N-m\u00e9thyltransf\u00e9rase) \u2014 la cible de <a href=\"https:\/\/medsbase.com\/fr\/5-amino-1mq\/\">5-Amino-1MQ<\/a>. NNMT consumes SAM to methylate nicotinamide; impaired B12 \/ methionine-synthase function lowers cellular SAM availability and therefore lowers NNMT activity indirectly. Studies that probes the NAD-axis \/ one-carbon-metabolism crossover often co-administers B12 and NNMT-pathway tools to dissect these connected biochemistries.<\/li>\n<\/ul>\n<p>The pharmacokinetic profile of injectable cyanocobalamin is well-characterised: IM or SC administration produces rapid systemic absorption with peak plasma concentrations at 1\u20132 hours; substantial dose-dependent renal clearance (the kidney saturates and dose-dumps any cyanocobalamin above the transcobalamin-II carrier capacity); cellular uptake then proceeds over hours-to-days; conversion to active coenzymes happens continuously thereafter; and the very low daily turnover requirement of cobalamin coenzymes (~2 \u00b5g\/d in human physiology) means that single high-dose injections produce sustained tissue-level effects for weeks. The 1 mg\/mL \u00d7 10 mL multi-dose format supports typical protocols ranging from single-bolus high-dose work to weekly or daily smaller-dose chronic dosing. <\/p>\n<h2>Published Evidence<\/h2>\n<p>B12 \/ cyanocobalamin is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>One-carbon metabolism and SAM-cycle studies<\/strong> \u2014 the canonical small-molecule cofactor for methionine synthase; standard tool compound for any studies that probes the folate \/ B12 \/ methionine \/ SAM axis; widely used in DNA-methylation and histone-methylation pharmacology studies<\/li>\n<li><strong>Homocysteine-axis studies<\/strong> \u2014 methionine synthase deficiency \/ impairment causes homocysteine accumulation; cyanocobalamin supplementation is the standard intervention in published studies models of hyperhomocysteinaemia and cardiovascular risk<\/li>\n<li><strong>Haematology and erythropoiesis studies<\/strong> \u2014 B12 deficiency causes megaloblastic anaemia via impaired DNA-methylation-dependent thymidine synthesis; published studies uses cyanocobalamin in vitamin-deficiency erythropoiesis models, bone-marrow culture studies, and reticulocyte-response studies<\/li>\n<li><strong>Peripheral neuropathy and demyelination studies<\/strong> \u2014 B12 deficiency causes peripheral neuropathy and subacute combined degeneration of the spinal cord via impaired phospholipid methylation in myelin sheaths; published studies uses cyanocobalamin supplementation in demyelination \/ remyelination model systems<\/li>\n<li><strong>NAD-axis \/ methylation crossover studies<\/strong> \u2014 combin\u00e9e avec <a href=\"https:\/\/medsbase.com\/fr\/5-amino-1mq\/\">5-Amino-1MQ<\/a> (inhibiteur de NNMT) ou <a href=\"https:\/\/medsbase.com\/fr\/nad\/\">NAD\u207a<\/a> in published studies that probes the SAM-cycle \/ nicotinamide-methylation node<\/li>\n<li><strong>Recovery and athletic-applications (combined with peptide protocols)<\/strong> \u2014 frequently included as a companion compound in protocols that combine peptide therapeutics (BPC-157, TB-500, GH peptides) with cofactor \/ vitamin support; the canonical small-molecule companion to peptide-axis recovery<\/li>\n<li><strong>Cognitive and nootropic-applications<\/strong> \u2014 combin\u00e9 avec des peptides cognitifs (<a href=\"https:\/\/medsbase.com\/fr\/selank\/\">Selank<\/a>, <a href=\"https:\/\/medsbase.com\/fr\/semax\/\">Semax<\/a>, <a href=\"https:\/\/medsbase.com\/fr\/dsip\/\">DSIP<\/a>) in studies on the cognitive sequelae of B12 deficiency and the cobalamin axis in CNS function<\/li>\n<li><strong>Cyanocobalamin vs methylcobalamin vs hydroxocobalamin comparative studies<\/strong> \u2014 published studies has compared the four cobalamin forms head-to-head for bioavailability, intracellular conversion kinetics, and tissue-retention profiles; cyanocobalamin is the canonical reference compound against which the others are benchmarked<\/li>\n<\/ul>\n<p>For broader context on small-molecule cofactor \/ coenzyme compounds in this catalogue, see <a href=\"https:\/\/medsbase.com\/fr\/l-carnitine\/\">L-Carnitine<\/a> (the closest small-molecule companion analogue \u2014 mitochondrial long-chain fatty-acid shuttle), <a href=\"https:\/\/medsbase.com\/fr\/nad\/\">NAD\u207a<\/a> (coenzyme dinucl\u00e9otide oxyd\u00e9 \u2014 suppl\u00e9mentation directe du pool NAD), <a href=\"https:\/\/medsbase.com\/fr\/5-amino-1mq\/\">5-Amino-1MQ<\/a> (inhibiteur de NNMT \u2014 relie le cycle B12\/m\u00e9thionine \u00e0 l'axe NAD), et <a href=\"https:\/\/medsbase.com\/fr\/mots-c\/\">MOTS-c<\/a> (peptide m\u00e9tabolique d\u00e9riv\u00e9 des mitochondries). Parcourez l'int\u00e9gralit\u00e9 du <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\">peptides &amp; compounds catalog<\/a>. <\/p>\n<h2>Tailles de conditionnement disponibles<\/h2>\n<p>MedsBase propose de la vitamine B12 (Cyanocobalamine) injectable en une seule concentration\/format de flacon avec trois options de taille d'emballage :<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Taille du pack<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Cas d'utilisation typique<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Mat\u00e9riel total<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>1 Flacon<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Single-experiment, dose-titration, or short-course in-vivo studies \u2014 10 mg total cyanocobalamin in 10 mL multi-dose format covers 4\u20138 weeks of typical protocol dosing in rodents or small-cohort cell-culture work<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 mg \/ 10 mL<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 Flacons<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Multi-cohort or extended-cycle studies \u2014 typical mid-scale protocols using B12 as a companion compound alongside peptide-dosing; per-vial economics improve significantly vs single-vial purchase<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50 mg \/ 50 mL<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 flacons<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Large-cohort or long-arm protocols \u2014 chronic-dosing companion supply alongside long-cycle peptide protocols; lowest per-mg cost; covers multi-animal cohort work without re-purchase<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100 mg \/ 100 mL<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The single 1-vial pack is convenient for single-experiment or titration work; the 5-vial and 10-vial packs provide significant per-vial savings for chronic protocols or multi-cohort studies. The 1 mg\/mL \u00d7 10 mL multi-dose format matches the standard pharmaceutical injectable cyanocobalamin pattern and is well-suited to typical protocol dosing \u2014 IM, SC, or IV administration of 100 \u00b5g to 1 mg per dose (equivalent to 0.1\u20131 mL of the supplied solution) covers essentially all published studies dose ranges. <\/p>\n<h2>Comparaison \u2014 B12 (Cyanocobalamine) vs L-Carnitine<\/h2>\n<p>La B12 et <a href=\"https:\/\/medsbase.com\/fr\/l-carnitine\/\">L-Carnitine<\/a> are the two best-characterised small-molecule companion compounds in this catalogue. Both serve as cofactor \/ shuttle compounds in mitochondrial and metabolic support, both are supplied in multi-dose injectable formats appropriate for protocol use alongside the peptide catalogue, and both are mechanistically distinct from the peptide compounds. The comparison illustrates the two canonical &#8220;small-molecule companion&#8221; compounds that users add to peptide protocols. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e8re<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">B12 (Cyanocobalamine)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">L-Carnitine<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Classe chimique<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Corrino\u00efde \u00e0 centre de cobalt (mol\u00e9cule unique)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">D\u00e9riv\u00e9 d'acide amin\u00e9 \u00e0 ammonium quaternaire (zwitterion unique)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1355,37 g\/mol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">161,20 g\/mol<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>R\u00f4le cellulaire<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cofacteur \u2014 m\u00e9thionine synthase (cytosolique, cycle SAM) + m\u00e9thylmalonyl-CoA mutase (mitochondriale, propionyl-CoA \u2192 TCA)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Transporteur de substrat \u2014 navette des acides gras \u00e0 longue cha\u00eene \u00e0 travers la membrane mitochondriale interne (entr\u00e9e dans la \u03b2-oxydation)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">One-carbon \/ methylation, homocysteine axis, megaloblastic erythropoiesis, demyelination studies, cognitive \/ nootropic crossover<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fat oxidation, mitochondrial bioenergetics, insulin sensitivity, sperm motility, cardiovascular metabolic support<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Approbation FDA<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Oui \u2014 la cyanocobalamine injectable est approuv\u00e9e pour la carence en vitamine B12 ; l'hydroxocobalamine approuv\u00e9e sous le nom Cyanokit (antidote au cyanure)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Oui \u2014 la l\u00e9vocarnitine est approuv\u00e9e pour les carences primaires\/secondaires en carnitine (voie orale et IV)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Besoins quotidiens de renouvellement<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tr\u00e8s faible (~2 \u00b5g\/j en physiologie humaine) \u2014 des injections \u00e0 dose unique \u00e9lev\u00e9e maintiennent les taux tissulaires pendant des semaines<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u00c9lev\u00e9 \u2014 le pool endog\u00e8ne de carnitine est d'environ 25 g ; les besoins quotidiens de remplacement dans les \u00e9tats de carence sont substantiels<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Forme fournie<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Solution aqueuse st\u00e9rile pr\u00e9formul\u00e9e (1 mg\/mL \u00d7 10 mL multidose)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Poudre lyophilis\u00e9e (reconstituer avec de l'eau BAC)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose typique<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100 \u00b5g \u00e0 1 mg par dose (0,1\u20131 mL de solution fournie), IM \/ SC \/ IV<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Des centaines de mg \u00e0 des niveaux de gramme par dose (protocoles pour rongeurs \/ grands animaux)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on one-carbon metabolism, SAM cycle, homocysteine axis, or megaloblastic erythropoiesis, B12 \/ cyanocobalamin is the canonical small-molecule companion. For studies focused on long-chain fatty-acid oxidation, mitochondrial bioenergetics, or insulin sensitivity, <a href=\"https:\/\/medsbase.com\/fr\/l-carnitine\/\">L-Carnitine<\/a> is the more targeted tool. The two compounds are commonly co-administered as part of broader peptide-protocols that benefit from both methylation-cycle and fatty-acid-oxidation cofactor support. <\/p>\n<h2>Stockage et manipulation<\/h2>\n<p><strong>Solution pr\u00e9formul\u00e9e \u2014 aucune reconstitution n\u00e9cessaire.<\/strong> Contrairement aux produits peptidiques lyophilis\u00e9s de ce catalogue, la cyanocobalamine injectable est fournie sous forme de solution aqueuse st\u00e9rile pr\u00eate \u00e0 l'emploi. Pr\u00e9levez aseptiquement avec une seringue st\u00e9rile \u00e0 chaque utilisation ; ne pas introduire de contaminants dans le flacon multidose. <strong>Stockage :<\/strong> conserver au r\u00e9frig\u00e9rateur entre 2 et 8 \u00b0C dans son emballage d'origine. <strong>Prot\u00e9ger de la lumi\u00e8re en permanence<\/strong> \u2014 cyanocobalamin is photosensitive (UV and short-wavelength visible light catalyses cyano-to-hydroxo and cyano-to-cob(II)alamin photoproducts). Store the vial in its original light-protective box or wrap in foil if removed. Avoid prolonged exposure to clinical ambient light during handling. <strong>Ne pas congeler.<\/strong> La formation de cristaux de glace peut fissurer le flacon en verre, et le stockage congel\u00e9 n'offre aucun avantage de stabilit\u00e9 au-del\u00e0 de la r\u00e9frig\u00e9ration pour une solution aqueuse d\u00e9j\u00e0 formul\u00e9e. La solution est stable entre 2 et 8 \u00b0C pendant au moins 24 mois \u00e0 partir de la date de fabrication \u00e0 l'\u00e9tat non ouvert. <strong>Apr\u00e8s la premi\u00e8re ponction :<\/strong> utilisez le flacon multidose dans les 60 jours. Le tampon pr\u00e9formul\u00e9 contient des conservateurs (g\u00e9n\u00e9ralement de l'alcool benzylique ou du ph\u00e9nol \u00e0 des concentrations pharmaceutiques) qui maintiennent la st\u00e9rilit\u00e9 lors d'une utilisation multidose, mais les ponctions r\u00e9p\u00e9t\u00e9es du septum finissent par risquer une contamination microbienne. Jetez le flacon en cas d'opacit\u00e9, de particules, de changement marqu\u00e9 de couleur (en particulier un \u00e9claircissement du rouge profond caract\u00e9ristique \u2014 indiquant une photod\u00e9gradation) ou de pr\u00e9cipitation. <\/p>\n<h2>Questions fr\u00e9quemment pos\u00e9es<\/h2>\n<h3>Pourquoi la solution de B12 fournie a-t-elle une couleur rouge profond ?<\/h3>\n<p>Le noyau corrine centr\u00e9 sur le cobalt des cobalamines est un chromophore puissant dans le spectre visible \u2014 les bandes d'absorption \u03bbmax de la cyanocobalamine \u00e0 ~360 nm (UV), ~520 nm (vert) et ~550 nm (vert-jaune) produisent la couleur transmise rose-rouge caract\u00e9ristique. Toute solution de cyanocobalamine doit appara\u00eetre d'un rouge intense ; un \u00e9claircissement vers le jaune ou le brun indique une photod\u00e9gradation (conversion cyano en hydroxo ou r\u00e9duction suppl\u00e9mentaire en cob(II)alamine) et le flacon doit \u00eatre jet\u00e9. <\/p>\n<h3>Pourquoi ce produit B12 utilise-t-il la forme cyano plut\u00f4t que la m\u00e9thyl- ou hydroxocobalamine ?<\/h3>\n<p>Cyanocobalamin is the standard form supplied as injectable B12 because it is photochemically and thermally the most stable of the cobalamin forms \u2014 the cyano group resists the photolytic degradation that affects methyl-, hydroxo-, and adenosylcobalamin in solution. Once cyanocobalamin enters cells, intracellular enzymes (MTRR, MMAA) convert it to the biologically-active methylcobalamin and adenosylcobalamin forms. For most applications, cyanocobalamin is therefore the practical choice. Users specifically studying methylcobalamin or hydroxocobalamin pharmacology (e.g., differential cellular-uptake kinetics, light-degradation pathways, or cyanide-antidote applications) require those specific forms separately. <\/p>\n<h3>Ce produit B12 est-il un peptide ?<\/h3>\n<p>Non. La cyanocobalamine est une coenzyme corrino\u00efde centr\u00e9e sur le cobalt de petite mol\u00e9cule (MW 1355,37 g\/mol), <em>re\u00e7oit pas<\/em> a peptide. We stock it in our peptide-studies catalogue as the canonical small-molecule companion compound used in protocols that combine peptide studies with cobalamin-axis biology. The spec table Sequence row is marked &#8220;n\/a&#8221; for this reason. Other small-molecule companions in this catalogue include <a href=\"https:\/\/medsbase.com\/fr\/l-carnitine\/\">L-Carnitine<\/a>, <a href=\"https:\/\/medsbase.com\/fr\/nad\/\">NAD\u207a<\/a>, <a href=\"https:\/\/medsbase.com\/fr\/5-amino-1mq\/\">5-Amino-1MQ<\/a>, et <a href=\"https:\/\/medsbase.com\/fr\/aicar-acadesine\/\">AICAR<\/a>. <\/p>\n<h3>What published dose ranges have been used in studies?<\/h3>\n<p>Injectable cyanocobalamin published dosing in human-clinical and rodent in-vivo work typically uses 100\u20131000 \u00b5g per dose (0.1\u20131.0 mL of the supplied 1 mg\/mL solution), IM or SC, daily for the first week and then weekly or monthly thereafter for chronic protocols. The 1000 \u00b5g single bolus is the canonical &#8220;loading dose&#8221; in clinical-translational studies. In-vitro cell-culture protocols typically use nanomolar to micromolar concentrations. Users should consult primary literature appropriate to the specific application (haematology, neuropathy, cardiovascular, one-carbon metabolism, etc.). <\/p>\n<h3>Can B12 be combined with peptides like Selank, Semax, or DSIP in protocols?<\/h3>\n<p>Oui \u2014 la B12 est couramment combin\u00e9e avec des peptides nootropes (<a href=\"https:\/\/medsbase.com\/fr\/selank\/\">Selank<\/a>, <a href=\"https:\/\/medsbase.com\/fr\/semax\/\">Semax<\/a>, <a href=\"https:\/\/medsbase.com\/fr\/dsip\/\">DSIP<\/a>) in studies on the cognitive sequelae of cobalamin deficiency and the broader cobalamin-axis contribution to CNS function. B12 is also commonly co-administered with recovery peptides (BPC-157, TB-500), growth-hormone peptides (<a href=\"https:\/\/medsbase.com\/fr\/sermorelin\/\">Sermorelin<\/a>, <a href=\"https:\/\/medsbase.com\/fr\/tesamorelin\/\">Tesamorelin<\/a>), et peptides m\u00e9taboliques (<a href=\"https:\/\/medsbase.com\/fr\/mots-c\/\">MOTS-c<\/a>) comme cofacteur compagnon. La forme aqueuse pr\u00e9formul\u00e9e signifie qu'elle peut \u00eatre pr\u00e9lev\u00e9e fra\u00eeche dans une seringue s\u00e9par\u00e9e pour chaque administration \u2014 ne pas m\u00e9langer avec d'autres solutions peptidiques dans la m\u00eame seringue, car le chromophore cobalt-corrine peut interagir avec les peptides contenant des thiols et induire des effets photoredox mineurs. <\/p>\n<h3>Pourquoi la cyanocobalamine est-elle parfois mentionn\u00e9e en lien avec le cyanure ?<\/h3>\n<p>The cyano group on cyanocobalamin is a very small amount of bound cyanide \u2014 when intracellular enzymes convert cyanocobalamin to the active methyl\/adenosyl forms, free cyanide is released in stoichiometric amount, but the quantity is very small (~25 \u00b5g of cyanide per 1 mg of cyanocobalamin) and is detoxified by the cellular rhodanese \/ thiosulfate system without clinical significance. The opposite reaction \u2014 cobalamin scavenging cyanide \u2014 is the basis of hydroxocobalamin&#8217;s approved use as a cyanide-antidote drug (Cyanokit), where high-dose hydroxocobalamin sequesters circulating cyanide as cyanocobalamin for renal excretion. Users in cyanide-antidote studies require hydroxocobalamin specifically, not cyanocobalamin. <\/p>\n<h3>How does this pharmaceutical-grade B12 compare with the existing branded B12 products on MedsBase?<\/h3>\n<p>Les produits B12 de marque existants sur MedsBase (par ex., <a href=\"https:\/\/medsbase.com\/fr\/vitamin-b12\/\">Comprim\u00e9s de vitamine B12 1500 mcg<\/a>) are clinical-pharmaceutical-grade B12 packaged in tablet form for oral \/ sublingual use, positioned in the nerve-health \/ energy-supplement category. The pharmaceutical-grade B12 supplied here is the injectable cyanocobalamin form in 10 mL multi-dose vial format, positioned in the peptide-studies catalogue as a small-molecule companion alongside the peptide compounds. Users requiring an oral \/ sublingual B12 supplement should use the tablet products; users requiring injectable cyanocobalamin for in-vivo or cell-culture work alongside peptide protocols can use the material supplied here. <\/p>\n<h3>Le B12 est-il sur la Liste des Interdictions de l'AMA ?<\/h3>\n<p>Non. La vitamine B12 \/ cyanocobalamine ne figure pas sur la Liste des Interdictions de l'AMA. C'est un compos\u00e9 vitaminique\/cofacteur couramment utilis\u00e9 \u00e0 la fois en clinique (pour le traitement des carences en B12) et comme compl\u00e9ment autoris\u00e9 dans les contextes sportifs. Il n'y a pas de restrictions r\u00e9glementaires sur la performance sportive concernant la cyanocobalamine ou d'autres formes de cobalamine. <\/p>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 20px 0 8px; border-radius: 4px; font-size: 14px;\"><strong>Why order compounds from MedsBase:<\/strong> Lyophilized HPLC \u226599% peptides &amp; compounds \u00b7 COA available on request \u00b7 Discreet protective packaging \u00b7 Worldwide courier \u00b7 <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance<\/a> sur chaque commande \u00b7 1 400+ v\u00e9rifi\u00e9s <a href=\"https:\/\/medsbase.com\/fr\/reviews\/\">avis clients<\/a><\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Small-Molecule Companion Compounds<\/h2>\n<ul>\n<li><a href=\"\/fr\/l-carnitine\/\"><strong>L-Carnitine<\/strong><\/a> \u2014 Mitochondrial fatty-acid shuttle \u2014 closest small-molecule companion analogue<\/li>\n<li><a href=\"\/fr\/nad\/\"><strong>NAD\u207a<\/strong><\/a> \u2014 Oxidised dinucleotide coenzyme \u2014 direct NAD-pool supplementation studies<\/li>\n<li><a href=\"\/fr\/5-amino-1mq\/\"><strong>5-Amino-1MQ<\/strong><\/a> \u2014 Inhibiteur de NNMT \u2014 relie le cycle B12\/m\u00e9thionine \u00e0 la m\u00e9thylation de l'axe NAD<\/li>\n<li><a href=\"\/fr\/aicar-acadesine\/\"><strong>AICAR<\/strong><\/a> \u2014 Canonical small-molecule AMPK activator \u2014 companion metabolic support compound<\/li>\n<li><a href=\"\/fr\/mots-c\/\"><strong>MOTS-c<\/strong><\/a> \u2014 Mitochondrial-derived metabolic peptide \u2014 alternative-mechanism cofactor studies<\/li>\n<li><a href=\"\/fr\/bac-water\/\"><strong>Eau BAC (Eau bact\u00e9riostatique)<\/strong><\/a> \u2014 N\u00e9cessaire pour reconstituer tout flacon lyophilis\u00e9 \u2014 diluant st\u00e9rile, conserv\u00e9 avec 0,9% d'alcool benzylique<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Cofacteur corrino\u00efde centr\u00e9 sur le cobalt \u2014 famille de la vitamine B12 (CAS 68-19-9)<br \/>\n\u2705 Solution aqueuse st\u00e9rile pr\u00e9formul\u00e9e (aucune reconstitution n\u00e9cessaire)<br \/>\n\u2705 1 mg\/mL \u00d7 10 mL multi-dose vial (10 mg total cyanocobalamin)<br \/>\n\u2705 Cofacteur de la m\u00e9thionine synthase cellulaire + m\u00e9thylmalonyl-CoA mutase<br \/>\n\u2705 Small-molecule companion compound (MW 1355.37, USP-grade)<\/p>\n<p><strong>Vitamine B12 (Cyanocobalamine) Injectable<\/strong> contient 1 mg\/mL \u00d7 10 mL de solution st\u00e9rile de cyanocobalamine.<\/p>","protected":false},"featured_media":71536,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6511,6510,6512,6513,6515,6514,3862],"class_list":["post-71466","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-cobalamin","product_tag-cyanocobalamin","product_tag-methionine-synthase-cofactor","product_tag-methylation-research","product_tag-research-companion","product_tag-small-molecule-research-compound","product_tag-vitamin-b12","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product\/71466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/comments?post=71466"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media\/71536"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media?parent=71466"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=71466"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=71466"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=71466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}